C4 Therapeutics Inc (CCCC)vsInsmed Inc (INSM)
CCCC
C4 Therapeutics Inc
$2.50
-2.34%
HEALTHCARE · Cap: $263.46M
INSM
Insmed Inc
$148.31
+6.59%
HEALTHCARE · Cap: $29.99B
Smart Verdict
WallStSmart Research — data-driven comparison
Insmed Inc generates 1587% more annual revenue ($606.42M vs $35.95M). INSM leads profitability with a -2.1% profit margin vs -2.9%. INSM earns a higher WallStSmart Score of 39/100 (F).
CCCC
Hold37
out of 100
Grade: F
INSM
Hold39
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Revenue surging 112.8% year-over-year
No standout strengths identified
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -44.4% — below average capital efficiency
Negative free cash flow — burning cash
1.5% revenue growth
0.0% earnings growth
Trading at 43.0x book value
ROE of -2.5% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : CCCC
The strongest argument for CCCC centers on Price/Book, Revenue Growth. Revenue growth of 112.8% demonstrates continued momentum.
Bull Case : INSM
PEG of 1.09 suggests the stock is reasonably priced for its growth.
Bear Case : CCCC
The primary concerns for CCCC are EPS Growth, Market Cap, Return on Equity.
Bear Case : INSM
The primary concerns for INSM are Revenue Growth, EPS Growth, Price/Book.
Key Dynamics to Monitor
CCCC profiles as a hypergrowth stock while INSM is a turnaround play — different risk/reward profiles.
CCCC carries more volatility with a beta of 2.94 — expect wider price swings.
CCCC is growing revenue faster at 112.8% — sustainability is the question.
CCCC generates stronger free cash flow (-22M), providing more financial flexibility.
Bottom Line
INSM scores higher overall (39/100 vs 37/100). Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
C4 Therapeutics Inc
HEALTHCARE · BIOTECHNOLOGY · USA
C4 Therapeutics, Inc., a biopharmaceutical company, develops new therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. The company is headquartered in Watertown, Massachusetts.
Insmed Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases. The company is headquartered in Bridgewater, New Jersey.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?